Lausanne, May 21th, 2019. Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of advanced bioinformatics solutions, announced today a partnership with Molecular Vision Laboratory (MVL), a CAP and CLIA-certified medical diagnostic laboratory based in Oregon, USA, providing comprehensive genetic NGS-based testing for inherited retinal dystrophies.
The Saphetor Portal has been updated to version 7 as of February 2nd 2019 under the new name VarSome Clinical. There are many changes since version 6, and this release brings our clinical platform up to date with the features, databases and classification visible in the free VarSome.com. Our clinical platform has been on the market since 2015 and is already being used by dozens of institutional clients, such as diagnostic laboratories, hospitals, and universities from countries all over the world.
Lausanne, Switzerland - November 26, 2018 - Saphetor SA, a Swiss precision medicine company and a leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing, announced today that Dr. Erik Zmuda has become a member of its Advisory Board.
Lausanne, Switzerland - November 20, 2018 - Saphetor SA, a Swiss precision-medicine company and leader in diagnostic and bioinformatics solutions for clinical Next Generation Sequencing (NGS), announced today a partnership with HPST, s.r.o., an authorized distributor of Agilent Technologies for the Czech Republic. Saphetor’s clinically-certified platform for fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels extends HPST portfolio of tools and services for a wide range of its clients employing NGS technologies for clinical as well as for research purposes.
LAUSANNE, Switzerland – Saphetor S.A. is proud to report that its entry in the recent “Precision FDA” contest, organised by the Food and Drug Administration, met with resounding success.